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Abstract
Background: The most common pattern of recurrence of gastric cancer (GC) is peritoneal dissemination. However,
rectal metastasis via hematogenous or lymphatic spread is exceedingly rare. We present a case of a 65-year-old
man with an intramucosal GC who developed a rectal recurrence, possibly via a hematogenous route.
Case presentation: A 65-year-old man underwent curative endoscopic submucosal dissections for the intramucosal
GCs at the anterior wall of the fornix twice. The third GC at the similar location was treated by radical laparoscopic
proximal gastrectomy; microscopic examination revealed well-differentiated tubular adenocarcinoma confined to the
lamina propria mucosae (T1aN0M0, stage IA). Follow-up colonoscopy revealed a 30-mm submucosal mass in the rectal
wall 2 years later, and a metastasis of gastric origin was suspected histopathologically. After a staging laparoscopy
confirmed the absence of findings suggestive of serosal involvement or peritoneal dissemination, including negative
peritoneal washing cytology, a laparoscopic low anterior resection with lymph node dissection was performed.
Microscopically, the tumor was found to mainly be located in the submucosal layer and showed features of moderately
differentiated tubular adenocarcinoma. The serosal surface was free of disseminated tumor. Lymph node metastases were
identified. Immunohistochemically, there were foci of carcinoma cells that were positive for cytokeratin 20; however, they
were negative for cytokeratin 7. Negative staining for caudal-type homeobox 2, a transcription factor indicating goblet
cell differentiation, combined with absence of intramucosal carcinoma in the rectal mucosa, suggested a diagnosis of
metastatic adenocarcinoma of gastric origin. The absence of evidence of peritoneal dissemination suggested
hematogenous or lymphatic spread.
Conclusion: Although rectal metastasis from GC, particularly when attributable to hematologic or lymphatic metastasis, is
very rare, metastatic gastric adenocarcinoma should be considered as a differential diagnosis for patients who present
with a rectal tumor and a past history of GC, even if it is an early GC.
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Background
Gastric cancer (GC) is the fourth most commonly diag-
nosed cancer and the second most common cause of
cancer mortality worldwide [1]. Despite improvements
in diagnosis and treatment, the prognosis of patients
with recurrent GC remains poor [2, 3], the recurrence
rate after curative surgery for GC reportedly ranging
from 20 to 50 % [4–8].
Based on the findings of pertinent studies, the recurrence
patterns after curative surgery for GC have been classified
as follows: (1) locoregional recurrence, (2) peritoneal recur-
rence, and (3) distant (including hematogenous) metastasis
[3, 6, 9–11]. Of these, metastasis of GC to the colorectal re-
gion by hematogenous or lymphatic spread is very rare.
There are a few English language reports of such cases
[12–16], all of which had advanced-stage disease. We re-
port a case of a metachronous rectal metastasis caused by
hematologic or lymphatic spread 2 years after curative re-
section of a recurrent intramucosal GC.
Case presentation
A 60-year-old man underwent endoscopic submucosal
dissection (ESD) for early GC at the anterior wall of
the fornix (Fig. 1a, upper). Microscopic examination of
the removed tissue established a diagnosis of well-
differentiated tubular adenocarcinoma of intestinal type
(Lauren classification) [17], which was confined to the
lamina propria mucosae (pT1a, the American Joint Com-
mittee on Cancer classification seventh edition). No ulcer
scar or lymphovascular invasion was identified, and the
surgical margins were free of tumor.
Thirteen months later, he underwent the second ESD
for the second early GC at the similar location (Fig. 1a,
lower), which was confirmed to be an intramucosal well-
differentiated tubular adenocarcinoma; the resection
margin was negative for tumor. Again, no ulcer scar or
lymphovascular invasion was identified. A perforation
that occurred during ESD was closed immediately by
clipping and was treated conservatively.
Three years after the second curative ESD, he under-
went laparoscopic proximal gastrectomy with lymph
node dissection for the third GC at the similar location
(Fig. 1b, upper and lower). The adjacent non-neoplastic
mucosa showed atrophic changes, and microscopic
examination of the specimen revealed well-differentiated
tubular adenocarcinoma, which was still confined to the
lamina propria (Fig. 1c). The morphologic features of
this tumor differed from those of the first and second
tumors; this one was diagnosed as being of gastric type.
Neither lymphatic nor venous invasion was identified,
and the surgical margins were free of tumor.
Two years after curative resection, a follow-up colonos-
copy revealed a rectal mass; the patient was asymptomatic.
The mass measured 30 mm in the greatest dimension and
appeared to be a submucosal tumor (Fig. 2a). Histopatho-
logic examination of an endoscopic, ultrasound-guided,
fine-needle aspiration biopsy established a diagnosis of in-
vasive adenocarcinoma with features similar to those of
Fig. 1 Findings of resected gastric cancers. a Gastroscopic images showing the first (upper) and second (lower) proximal gastric cancers. b Gastroscopic
image of the third proximal gastric cancer (upper) and the macroscopic appearance of the resected proximal gastric specimen (lower). c Photomicrograph
of a section from the resected gastric cancer showing well-differentiated tubular adenocarcinoma (hematoxylin and eosin stain, ×40)
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the GC resected 2 years previously. The serum level of
carcinoembryonic antigen was slightly increased at
8.8 mg/mL, and fluorodeoxyglucose positron emission
tomography-computed tomography showed high uptake
in part of the rectal mass and regional lymph nodes (max-
imum standard uptake values being 8.8 and 3.2, respect-
ively); however, there was no evidence of distant
metastasis or peritoneal dissemination (Fig. 2b). Barium
enema X-ray films showed the tumor at Ra-Rs (Fig. 2c).
After a staging laparoscopy confirmed the absence of find-
ings suggestive of serosal involvement or peritoneal
dissemination, including negative peritoneal washing cy-
tology, a laparoscopic low anterior resection with lymph
node dissection was performed (Fig. 2d).
Microscopically, the tumor was found to mainly be
located in the submucosal layer and showed features of
moderately differentiated tubular adenocarcinoma
(Fig. 3a). Lymph node metastases were identified.
There was lymphatic invasion (ly1) and venous inva-
sion (v1). The serosal surface was free of disseminated
tumor. Immunohistochemically, there were foci of
carcinoma cells that were positive for cytokeratin 20
(Fig. 3b); however, they were negative for cytokeratin 7
(Fig. 3c). Negative staining for caudal-type homeobox 2, a
transcription factor indicating goblet cell differentiation,
combined with absence of intramucosal carcinoma in the
rectal mucosa (Fig. 3d), suggested a diagnosis of metastatic
adenocarcinoma of gastric origin. Morphologically, the
tumor was similar to the third tumor excised. Because the
peritoneal surface was unaffected both grossly and micro-
scopically, the route of metastatic spread was considered
to be hematogenous or lymphatic. The patient was alive
with no evidence of recurrent tumor on imaging studies
6 months after the final surgery.
The recurrence patterns after curative surgery for GC
have been classified as follows: (1) locoregional recur-
rence, (2) peritoneal recurrence, and (3) distant (includ-
ing hematogenous) metastasis [3, 6, 9–11, 18]. The most
common pattern of spread of these tumors is via peri-
toneal dissemination. As to distant metastases, intes-
tinal metastasis from GC is rare; however, the most
common cause of secondary neoplastic infiltration of
the colon is GC [19]. Metastatic colonic lesions can
occur by direct extension of the initial primary GC via
the gastrocolic ligament, peritoneal metastasis, or
hematologic or lymphatic dissemination [13, 19].
Hematologic or lymphatic spread from a GC to the
rectum is extremely rare. We here report a metastatic
rectal lesion with no associated peritoneal dissemin-
ation. To the best of our knowledge, there are only five
English language reports of such cases (Table 1) [12–16].
Two of these were considered to have spread via the
hematogenous route, whereas the route of spread in the
other three cases was unclear. This is the first English lan-
guage report of metachronous rectal metastasis from an
“early” GC caused by hematologic or lymphatic metastasis.
Fig. 2 Preoperative findings and resected rectum specimen. a Colonoscopy image showing a 30-mm rectal mass that appears to be a submucosal
tumor. b Fluorodeoxyglucose positron emission tomography-computed tomography image showing abnormally high uptake in part of the tumor
and regional lymph nodes. c Contrast enema film showing deformation of the rectum. d Macroscopic appearance of the resected rectum specimen.
There is no evidence of exposure of tumor or peritoneal dissemination
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Although a perforation did occur during the second ESD in
our case, there was no evidence of exposure of tumor, peri-
toneal dissemination, or cancerous ascites. Thus, the intra-
operative and pathological findings suggested that the
metastatic rectal lesion was attributable to hematologic or
lymphatic metastasis rather than peritoneal dissemination.
In addition, in all previous reports of rectal metastasis
unassociated with peritoneal dissemination, the patients
had advanced GC, whereas our case was categorized as
T1aN0M0 stage IA by histological examination. Thus, our
case indicates that even patients with “early” GC may de-
velop rectal recurrence by hematologic or lymphatic spread
without peritoneal dissemination.
There are only a few published studies regarding surgi-
cal treatment of GC recurrence. According to several re-
ports on the role and outcomes of surgical treatment for
non-hepatic intra-abdominal recurrences from GC, sur-
gical resection is the treatment of choice for selected pa-
tients in whom the recurrent tumors are completely
resectable [20, 21]. Nunobe et al. reported the outcomes
of surgery with curative intent in 36 selected patients
with locoregional recurrence. Their median survival after
surgery was about 23 months, seven of the 36 patients
(19.4 %) surviving more than 3 years after surgery [22].
In the present case, the factors favoring curative surgical
resection were that there was no evidence of exposure of
tumor or peritoneal dissemination, the recurrence had
appeared late and was isolated, and the intra-abdominal
recurrent tumor could be completely resected en bloc.
Interestingly, our case confirms what others have re-
ported: that metastatic lesions may have regional lymph-
atic metastases like primary rectal cancer (Table 1).
Ogiwara et al. reported a case of polypoid colonic metas-
tases with regional lymph node metastases 11 years after
the resection of a GC [12]. Additionally, Pace et al. re-
ported a case of a signet ring cell carcinoma of the stom-
ach metastasizing to the ascending colon with regional
lymph node metastases [13]. Therefore, it is necessary to
investigate for possible lymphatic metastases preopera-
tively and perform systematic lymph node dissection if
indicated when resecting a recurrent tumor.
In the recent studies, a local recurrence rate after
curative ESD for GC is generally low (in the range 0.1–
1.1 %) [23, 24]. On the other hand, a higher incidence of
metachronous GCs (in the range 1.8–15.9 %) has been
reported [24–27]. In the present case, all three GCs were
located at the similar part, the anterior wall of the fornix.
However, the pathological records of the first and sec-
ond ESDs demonstrated that those ESDs were per-
formed curatively, and three tumors did not have any
specific characteristics. Considering the rates of local
recurrence and metachronous GC, it is extremely
difficult to consider that local recurrence occurred
twice after curative ESDs. Rather, it is possible that
Fig. 3 Analysis of rectal tumor by immunohistochemistry. a Photomicrograph showing moderately differentiated tubular adenocarcinoma mainly
in the submucosal layer without serosal exposure (hematoxylin and eosin stain, ×12.5). b–d Immunohistochemical staining showed the tumor
cells are positive for cytokeratin 20 and negative for cytokeratin 7 and caudal-type homeobox 2
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Table 1 Literature reports of colorectal recurrence from gastric cancer









1. 1994 Ogiwara et al. 53 F por NA NA D Yes por 660 Unknown NA
2. 2009 Pace U et al. 77 M por
sig
TisN2Mx IIIB NA A Yes por
sig
14 None NA
3. 2011 Lim S W et al. 43 F por T4aN0M0 IIB Hematologic R No por 34 Present 36M alive
4. 2012 Tural D et al. 74 F well NA Hematologic ? R NA NA – No operation
Chemotherapy
Alive
5. 2014 Sung Young Oh 69 F por T2N1M0 IIA NA S NA por 47 No operation
Chemotherapy
Alive
6. 2015 Our case 63 M well T1aN0M0 IA Hematologic
or lymphatic
R Yes mod 28 None 6M alive
Abbreviations: por Poorly differentiated adenocarcinoma, sig Signet-ring cell carcinoma, mod moderately differentiated type, A ascending colon, D descending colon, DFI disease-free interval, GC gastric cancer, NA not












metachronous GCs occurred twice after curative ESD
at the similar part.
In summary, we found the tumor at the rectum which
appeared to be a submucosal tumor, and there were no
findings of serosal exposure of tumor, peritoneal dissem-
ination, and cancerous ascites. These findings support
that the metastatic rectal lesion was due to hematologic
or lymphatic dissemination, but not peritoneal metasta-
sis. In our case, at least two distinct types of GCs,
namely a gastric type and a Lauren’s intestinal type, were
identified by gastrectomy and ESD, respectively. How-
ever, which type of GC caused rectal metastasis was ob-
scured. Importantly, we confirmed that a rectal tumor
was derived from an intramucosal GC, which is an ex-
tremely rare event.
Conclusions
We here report a case of rectal metastasis caused by
hematologic or lymphatic metastasis 2 years after cura-
tive resection for “early” GC. Although rectal metastasis
from GC, particularly when attributable to hematologic
or lymphatic metastasis, is very rare, metastatic gastric
adenocarcinoma should be considered as a differential
diagnosis for patients who present with a rectal tumor
and a past history of GC, even if it is an early GC.
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